Clinical Observation of Recombinant Human Coagulation FactorⅦa in Patients with Intractable Blood Loss
QIU Wen-feng
LUO Wei-wen
Abstract：Objective:To observe the clinical present situation of recombinant human coagulation factorⅦa in patients with intractable blood loss, increase awareness about the hemoslatic medicine,improve the clinical application.Method:A retrospective analysis was made to investigate the effect about rFⅦa in patients with intractable blood loss in 40 cases.There were 40 cases,15 cases after cardiac surgery,10 cases after chest surgery,5 cases of hepatobiliary,7 cases of coagulation disorders injury,3 cases of gastrointestinal stress ulcer bleeding.40 cases were treated with rFⅦa.The amount of bleeding, the blood transfusion volume,the total volume of blood transfusion 3 hours before treated with rFⅦa contrast 3 hours after treated with rFⅦa.Result:38 cases were cured successfully,2 cases dead.Conclusion:38 cases treated with rFⅦa,after 3 hours the amount of bleeding were sharp reducing,the blood transfusion volume and the total volume of blood transfusion were sharp slowdown.Patients with intractable blood loss,the conventional method unable valid stanch bleeding, ought to positive recommend treaded with rFⅦa.
Keywords：rFⅦaIntractable blood lossClinical observation
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：2( 14-15 )